Page 341 - Read Online

Page 20 of 20 Varikuti et al. Vessel Plus 2020;4:28 I http://dx.doi.org/10.20517/2574-1209.2020.27

159. Petkova SB, Tanowitz HB, Magazine HI, Factor SM, Chan J, et al. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi
infection. Cardiovasc Pathol 2000;9:257-65.
160. Herrera RN, Diaz de Amaya EI, Perez Aguilar RC, Joo Turoni C, Maranon R, et al. Inflammatory and prothrombotic activation with
conserved endothelial function in patients with chronic, asymptomatic Chagas disease. Clin Appl Thromb Hemost 2011;17:502-7.
161. Molina-Berrios A, Campos-Estrada C, Lapier M, Duaso J, Kemmerling U, et al. Protection of vascular endothelium by aspirin in a murine
model of chronic Chagas’ disease. Parasitol Res 2013;112:2731-9.
162. Molina-Berrios A, Campos-Estrada C, Lapier M, Duaso J, Kemmerling U, et al. Benznidazole prevents endothelial damage in an
experimental model of Chagas disease. Acta Trop 2013;127:6-13.
163. Gonzalez-Herrera F, Cramer A, Pimentel P, Castillo C, Liempi A, et al. Simvastatin attenuates endothelial activation through 15-Epi-
Lipoxin A4 production in murine chronic chagas cardiomyopathy. Antimicrob Agents Chemother 2017;61.
164. de Pablos Torro LM, Retana Moreira L, Osuna A. Extracellular vesicles in chagas disease: a new passenger for an old disease. Front
Microbiol 2018;9:1190.
165. Tkach M, Thery C. Communication by extracellular vesicles: where we are and where we need to go. Cell 2016;164:1226-32.
166. Penfornis P, Vallabhaneni KC, Whitt J, Pochampally R. Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor
microenvironment. Int J Cancer 2016;138:14-21.
167. Jazin EE, Bontempi EJ, Sanchez DO, Aslund L, Henriksson J, et al. Trypanosoma cruzi exoantigen is a member of a 160 kDa gene
family. Parasitology 1995;110:61-9.
168. Franco JR, Simarro PP, Diarra A, Jannin JG. Epidemiology of human African trypanosomiasis. Clin Epidemiol 2014;6:257-75.
169. Morrison LJ. Parasite-driven pathogenesis in Trypanosoma brucei infections. Parasite Immunol 2011;33:448-55.
170. Sternberg JM, Maclean L. A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence.
Parasitology 2010;137:2007-15.
171. Gull K. The cell biology of parasitism in Trypanosoma brucei: insights and drug targets from genomic approaches? Curr Pharm Des
2002;8:241-56.
172. Amin DN, Rottenberg ME, Thomsen AR, Mumba D, Fenger C, et al. Expression and role of CXCL10 during the encephalitic stage of
experimental and clinical African trypanosomiasis. J Infect Dis 2009;200:1556-65.
173. Viswambharan H, Seebeck T, Yang Z. Enhanced endothelial nitric oxide-synthase activity in mice infected with Trypanosoma brucei. Int
J Parasitol 2003;33:1099-104.
174. Rodgers J, Steiner I, Kennedy PGE. Generation of neuroinflammation in human African trypanosomiasis. Neurol Neuroimmunol
Neuroinflamm 2019;6.
175. Magez S, Lucas R, Darji A, Songa EB, Hamers R, et al. Murine tumour necrosis factor plays a protective role during the initial phase of
the experimental infection with Trypanosoma brucei brucei. Parasite Immunol 1993;15:635-41.
176. Devhare PB, Ray RB. A novel role of exosomes in the vaccination approach. Ann Transl Med 2017;5:23.
177. Coakley G, Maizels RM, Buck AH. Exosomes and other extracellular vesicles: the new communicators in parasite infections. Trends
Parasitol 2015;31:477-89.
178. Eliaz D, Kannan S, Shaked H, Arvatz G, Tkacz ID, et al. Exosome secretion affects social motility in Trypanosoma brucei. PLoS Pathog
2017;13:e1006245.
179. Amole BO, Clarkson AB Jr, Shear HL. Pathogenesis of anemia in Trypanosoma brucei-infected mice. Infect Immun 1982;36:1060-8.
180. Paulnock DM, Freeman BE, Mansfield JM. Modulation of innate immunity by African trypanosomes. Parasitology 2010;137:2051-63.
181. Geiger A, Hirtz C, Becue T, Bellard E, Centeno D, et al. Exocytosis and protein secretion in Trypanosoma. BMC Microbiol 2010;10:20.